galantamine has been researched along with Palsy in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di, R; Lawton, MA; Long, C; Wang, H; Wang, Y; Wu, WH; Xin, L; Yamujala, R | 1 |
Clark, MG; Finneran, K; Hilmas, CJ; Poole, MJ; Williams, PT | 1 |
SKLIAROVA, TU | 1 |
GEORGIEV, I; MILEV, M; SEDLOEV, S | 1 |
MOIRAGHI, P | 1 |
Göpel, W | 1 |
Batskusheb, S; Mtsmkob, B | 1 |
1 trial(s) available for galantamine and Palsy
Article | Year |
---|---|
[Nivaline in neurological therapy (report of 100 cases)].
Topics: Adult; Aged; Central Nervous System Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Galantamine; Humans; Injections, Subcutaneous; Male; Neuromuscular Diseases; Paralysis; Peripheral Nervous System Diseases | 1971 |
6 other study(ies) available for galantamine and Palsy
Article | Year |
---|---|
Acetylcholineestarase-inhibiting alkaloids from Lycoris radiata delay paralysis of amyloid beta-expressing transgenic C. elegans CL4176.
Topics: Acetylcholinesterase; Alzheimer Disease; Amaryllidaceae Alkaloids; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Cholinesterase Inhibitors; Disease Models, Animal; Galantamine; Gene Expression; Humans; Longevity; Lycoris; Oxidative Stress; Paralysis; Peptide Fragments; Phenanthridines | 2013 |
Galantamine is a novel post-exposure therapeutic against lethal VX challenge.
Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterase Reactivators; Diaphragm; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Erythrocytes; Galantamine; Guinea Pigs; Male; Muscle Fatigue; Muscle Tonus; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Paralysis; Phrenic Nerve; Pralidoxime Compounds; Seizures; Time Factors | 2009 |
[On treatment of paralyses of the ocular muscles with Nivaline].
Topics: Galantamine; Humans; Ophthalmoplegia; Paralysis; Parasympathomimetics | 1962 |
ON THE EFFECT OF NIVALIN UPON INTESTINAL PERISTALSIS.
Topics: Drug Therapy; Galantamine; Gastrointestinal Motility; Humans; Intestinal Diseases; Intestine, Small; Intestines; Paralysis; Peristalsis; Postoperative Complications; Toxicology; Urinary Bladder Diseases | 1964 |
[Nivaline therapy in residual hemiparesis from cerebral vascular disorders].
Topics: Anticholesteremic Agents; Cerebrovascular Disorders; Galantamine; Humans; Intracranial Arteriosclerosis; Paralysis; Paresis | 1962 |
[Nivalin in rehabilitation of residual paralysis after cerebrovascular accidents].
Topics: Adult; Aged; Cerebrovascular Disorders; Drug Synergism; Female; Galantamine; Humans; Male; Middle Aged; Paralysis; Time Factors; Triazines | 1970 |